| Gene symbol | TNFRSF17 | Synonyms | BCM, BCMA, CD269, TNFRSF13A | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p13.13 | dbXrefs | |
| Description | TNF receptor superfamily member 17 | ||||
| GTO ID | GTC3276 |
| Trial ID | NCT05652530 |
| Disease | Multiple Myeloma |
| Altered gene | BCMA |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-NK cell |
| Treatment | BCMA CAR-NK cells |
| Phase | Early_Phase1 |
| Recruitment status | Recruiting |
| Title | Clinical Study of the Safety and Efficacy of BCMA CAR-NK |
| Year | 2022 |
| Country | China |
| Company sponsor | Shenzhen Pregene Biopharma Co., Ltd. |
| Cohort 1 | |||||||||
|
|||||||||